Healthy Clinical Trial
Official title:
Cadence Modulation to Improve Well-Being, Kinematics and Aerobic Performance in Cyclists
Verified date | April 2019 |
Source | University of Wisconsin, Madison |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will utilize a combination of cardiovascular analysis, 3D motion capture, and a software package, Metrifit, to monitor measures of well-being to comprehensively evaluate both the musculoskeletal and physiological responses following a HIIT training intervention at EOC as a means of improving performance and potentially reducing injury risk factors. This holistic approach of physiological and biomechanical factors is unprecedented. This is the first interventional study to determine the effect of high intensity training at EOC on cardiovascular performance, kinematics and well-being which may minimize risk of injury factors.
Status | Completed |
Enrollment | 25 |
Est. completion date | April 2, 2019 |
Est. primary completion date | April 2, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 89 Years |
Eligibility |
Inclusion Criteria: 1. An experienced cyclist will be defined as one with at least 5 years of cycling experience and 5000 miles of training on a road bike with a clipless pedal system. 2. Able to tolerate strenuous, maximal exercise and comply with a 6 week training protocol 3. Have access to an indoor trainer or spin bike with a cadence sensor in order to train 3 times per week for 60 minutes Exclusion Criteria: 1. Taking medication which could impact cardiovascular function or performance (stimulants, beta-blockers, e.g.) 2. Significant cardiac or pulmonary disease (congenital cardiac disease, uncontrolled hypertension, uncontrolled asthma, e.g.) 3. Musculoskeletal injuries that preclude a maximal cycling effort and participation in training program |
Country | Name | City | State |
---|---|---|---|
United States | University of Wisconsin | Madison | Wisconsin |
Lead Sponsor | Collaborator |
---|---|
University of Wisconsin, Madison |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Time to exhaustion T(max) | time to reach exhaustion | Baseline | |
Primary | Ventilatory threshold (VT) | Baseline | ||
Primary | Maximal cardiac output | Baseline | ||
Primary | Maximal stroke volume | Baseline | ||
Primary | decreased trunk lean | decrease in degree of lean in truck | Baseline | |
Primary | decreased ankle dorsiflexion | decrease in amount of ankle dorsiflexion | Baseline | |
Primary | decreased knee splay | decreased degree of knee splay | Baseline | |
Secondary | Improved VO2 max | Increased maximum O2 volume | 6 weeks | |
Secondary | Increased O2 consumption at VT | Improved oxygen consumption at ventilatory threshold | 6 weeks | |
Secondary | Time to VT | Improved time to reach ventilatory threshold | 6 weeks | |
Secondary | Time to T(max) | Improved time to reach exhaustion | 6 weeks | |
Secondary | decreased trunk lean | decrease in degree of lean in truck | 6 weeks | |
Secondary | decreased ankle dorsiflexion | decrease in amount of ankle dorsiflexion | 6 weeks | |
Secondary | decreased knee splay | decreased degree of knee splay | 6 weeks | |
Secondary | change in overall soreness and fatigue | decrease in reported soreness and fatigue as measured and reported via Metrifit software | 6 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |